| Name | Title | Contact Details |
|---|
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
Shiseido Cosmetics America Ltd. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Shiseido Cosmetics America Ltd. is based in New York, NY. You can find more information on Shiseido Cosmetics America Ltd. at www.sca.shiseido.com
Millions of Patients around the world are standing up and taking an active role in their health, including supporting the care innovations that matter most to them. MedStartr enables patients, doctors, institutions, partners, and investors to find and fund the best ideas in healthcare and bring them to life. Join us today!
Polyfoam Corp is a Northbridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dental USA Inc is a Mchenry, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.